Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre C Kalil

Showing results (141-150 of 277) with videos related to

Pageof 28
Sort By:
Critical Care Medicine|March 26, 2026
Inhaled Antibiotics for Ventilator-Associated Pneumonia: Is It Ready for Prime Time?Andre C Kalil, Pedro Povoa, Paulo Mergulhao, et al.
The Cochrane Database of Systematic Reviews|January 20, 2012
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumoniaDanilo Cortozi Berton, Andre C Kalil, Paulo José Zimermann Teixeira
Antimicrobial Agents and Chemotherapy|October 24, 2019
Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?Andre C Kalil, Marisa Holubar, Stan Deresinski, et al.
BMJ Open|October 16, 2013
Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysisAndre C Kalil, Michael Klompas, Gleb Haynatzki, et al.
The Cochrane Database of Systematic Reviews|October 30, 2014
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumoniaDanilo Cortozi Berton, Andre C Kalil, Paulo José Zimermann Teixeira
Open Forum Infectious Diseases|December 12, 2022
Adjunctive Rifampin Following Debridement and Implant Retention for Staphylococcal Prosthetic Joint Infection: Is it Effective if not Combined With a Fluoroquinolone?Nicolás W Cortés-Penfield, Angela L Hewlett, Andre C Kalil
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 4, 2025
Decoding COVID-19: Phenotypes and the Pursuit of Precision MedicineSias J Scherger, Carlos A Gomez, Anum Abbas, et al.
Journal of Clinical Microbiology|December 30, 2011
Pediococcus acidilactici endocarditis successfully treated with daptomycinPeter C Iwen, Cezarina Mindru, Andre C Kalil, et al.
Critical Care Medicine|January 10, 2017
Early Goal-Directed Therapy for Sepsis: A Novel Solution for Discordant Survival Outcomes in Clinical TrialsAndre C Kalil, Daniel W Johnson, Steven J Lisco, et al.
Annals of the American Thoracic Society|April 29, 2022
The Potential for Increasing Risk of Consent Refusal in COVID-19 Trials: Considering Underlying Reasons and ResponsesJames A Russell, Keith R Walley, Andre C Kalil, et al.
Pageof 28

Showing results (141-150 of 277) with videos related to

Sort By:
Pageof 28
Critical Care Medicine|March 26, 2026
Inhaled Antibiotics for Ventilator-Associated Pneumonia: Is It Ready for Prime Time?Andre C Kalil, Pedro Povoa, Paulo Mergulhao, et al.
The Cochrane Database of Systematic Reviews|January 20, 2012
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumoniaDanilo Cortozi Berton, Andre C Kalil, Paulo José Zimermann Teixeira
Antimicrobial Agents and Chemotherapy|October 24, 2019
Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?Andre C Kalil, Marisa Holubar, Stan Deresinski, et al.
BMJ Open|October 16, 2013
Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysisAndre C Kalil, Michael Klompas, Gleb Haynatzki, et al.
The Cochrane Database of Systematic Reviews|October 30, 2014
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumoniaDanilo Cortozi Berton, Andre C Kalil, Paulo José Zimermann Teixeira
Open Forum Infectious Diseases|December 12, 2022
Adjunctive Rifampin Following Debridement and Implant Retention for Staphylococcal Prosthetic Joint Infection: Is it Effective if not Combined With a Fluoroquinolone?Nicolás W Cortés-Penfield, Angela L Hewlett, Andre C Kalil
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 4, 2025
Decoding COVID-19: Phenotypes and the Pursuit of Precision MedicineSias J Scherger, Carlos A Gomez, Anum Abbas, et al.
Journal of Clinical Microbiology|December 30, 2011
Pediococcus acidilactici endocarditis successfully treated with daptomycinPeter C Iwen, Cezarina Mindru, Andre C Kalil, et al.
Critical Care Medicine|January 10, 2017
Early Goal-Directed Therapy for Sepsis: A Novel Solution for Discordant Survival Outcomes in Clinical TrialsAndre C Kalil, Daniel W Johnson, Steven J Lisco, et al.
Annals of the American Thoracic Society|April 29, 2022
The Potential for Increasing Risk of Consent Refusal in COVID-19 Trials: Considering Underlying Reasons and ResponsesJames A Russell, Keith R Walley, Andre C Kalil, et al.
Pageof 28